| 11378491
|
Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces. |
J Clin Virol |
2001 |
Ostroff R;Ettinger A;La H;Rihanek M;Zalman L;Meador J 3rd;Patick AK;Worland S;Polisky B |
View
More |
| 1338980
|
Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2. |
Protein Sci |
1992 |
Tormo J;Stadler E;Skern T;Auer H;Kanzler O;Betzel C;Blaas D;Fita I |
View
More |
| 1373343
|
Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A. |
Cancer Immunol Immunother |
1992 |
Hayashi Y;Hoon DS;Park MS;Terasaki PI;Morton DL |
View
More |
| 15228398
|
Vaccination for asthma exacerbations. |
Intern Med J |
2004 |
Bardin PG |
View
More |
| 15755565
|
On the need for, and the delivery of, cross-protective vaccines. |
Vaccine |
2005 |
Spier RE |
View
More |
| 169804
|
Serotyping of avian infectious bronchitis viruses by the virus-neutralization test. |
Avian Dis |
1975 |
Cowen BS;Hitchner SB |
View
More |
| 1701477
|
Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. |
J Gen Virol |
1990 |
Kobayashi N;Taniguchi K;Urasawa S |
View
More |
| 1722503
|
Proliferative responses of T cells primed against human rhinovirus to other rhinovirus serotypes. |
J Gen Virol |
1991 |
Hastings GZ;Rowlands DJ;Francis MJ |
View
More |
| 172561
|
Human responses to two decavalent rhinovirus vaccines. |
J Infect Dis |
1975 |
Hamory BH;Hamparian VV;Conant RM;Gwaltney JM Jr |
View
More |
| 174011
|
Serological differentiation of bovine rhinoviruses. |
Natl Inst Anim Health Q (Tokyo) |
1975 |
Kurogi H;Inaba Y;Takahashi E;Sato K;Goto Y |
View
More |
| 176887
|
Is a rhinovirus vaccine possible? |
Am J Epidemiol |
1976 |
Fox JP |
View
More |
| 19403680
|
Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. |
J Virol |
2009 |
Katpally U;Fu TM;Freed DC;Casimiro DR;Smith TJ |
View
More |
| 19414783
|
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. |
J Immunol |
2009 |
Edlmayr J;Niespodziana K;Linhart B;Focke-Tejkl M;Westritschnig K;Scheiblhofer S;Stoecklinger A;Kneidinger M;Valent P;Campana R;Thalhamer J;Popow-Kraupp T;Valenta R |
View
More |
| 209768
|
Gel double immunodiffusion studies with sex human rhinoviruses. |
Arch Virol |
1978 |
Smith CB |
View
More |
| 2166081
|
Serotype 3 human rotavirus strains with subgroup I specificity. |
J Clin Microbiol |
1990 |
Gerna G;Sarasini A;Di Matteo A;Zentilin L;Miranda P;Parea M;Baldanti F;Arista S;Milanesi G;Battaglia M |
View
More |
| 2170576
|
Detection and differentiation of picornaviruses in clinical samples following genomic amplification. |
J Gen Virol |
1990 |
Olive DM;Al-Mufti S;Al-Mulla W;Khan MA;Pasca A;Stanway G;Al-Nakib W |
View
More |
| 22742898
|
Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. |
Antiviral Res |
2012 |
McLean GR;Walton RP;Shetty S;Peel TJ;Paktiawal N;Kebadze T;Gogsadze L;Niespodziana K;Valenta R;Bartlett NW;Johnston SL |
View
More |
| 23950960
|
Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C. |
PLoS One |
2013 |
Iwasaki J;Smith WA;Stone SR;Thomas WR;Hales BJ |
View
More |
| 24086140
|
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. |
PLoS Pathog |
2013 |
Glanville N;McLean GR;Guy B;Lecouturier V;Berry C;Girerd Y;Gregoire C;Walton RP;Pearson RM;Kebadze T;Burdin N;Bartlett NW;Almond JW;Johnston SL |
View
More |
| 2413124
|
Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes. |
J Immunol |
1985 |
Jennings SR |
View
More |
| 2416951
|
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. |
J Virol |
1986 |
Sherry B;Mosser AG;Colonno RJ;Rueckert RR |
View
More |
| 2437322
|
Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. |
J Virol |
1987 |
Taniguchi K;Morita Y;Urasawa T;Urasawa S |
View
More |
| 2460866
|
Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. |
Proc Natl Acad Sci U S A |
1988 |
Ping LH;Jansen RW;Stapleton JT;Cohen JI;Lemon SM |
View
More |
| 24767874
|
Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection. |
J Allergy Clin Immunol |
2014 |
Iwasaki J;Smith WA;Khoo SK;Bizzintino J;Zhang G;Cox DW;Laing IA;Le Souef PN;Thomas WR;Hales BJ |
View
More |
| 25799541
|
Epidemic 2014 enterovirus D68 cross-reacts with human rhinovirus on a respiratory molecular diagnostic platform. |
PLoS One |
2015 |
McAllister SC;Schleiss MR;Arbefeville S;Steiner ME;Hanson RS;Pollock C;Ferrieri P |
View
More |
| 26137535
|
Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms. |
EBioMedicine |
2015 |
Niespodziana K;Cabauatan CR;Jackson DJ;Gallerano D;Trujillo-Torralbo B;Del Rosario A;Mallia P;Valenta R;Johnston SL |
View
More |
| 2824684
|
Direct detection of rhinoviruses by an enzyme-linked immunosorbent assay. |
J Med Virol |
1987 |
Dearden CJ;Al-Nakib W |
View
More |
| 3023662
|
Diarrheal response of gnotobiotic pigs after fetal infection and neonatal challenge with homologous and heterologous human rotavirus strains. |
J Virol |
1986 |
Torres A;Ji-Huang L |
View
More |
| 3034822
|
Relationship of Theiler\'s murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. |
Intervirology |
1986 |
Nitayaphan S;Omilianowski D;Toth MM;Parks GD;Rueckert RR;Palmenberg AC;Roos RP |
View
More |
| 31003914
|
Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity. |
Vaccine |
2019 |
Sam Narean J;Glanville N;Nunn CM;Niespodziana K;Valenta R;Johnston SL;McLean GR |
View
More |
| 31416365
|
Overview of human rhinovirus immunogenic epitopes for rational vaccine design. |
Expert Rev Vaccines |
2019 |
Stepanova E;Isakova-Sivak I;Rudenko L |
View
More |
| 31940481
|
T-bet+ Memory B Cells Link to Local Cross-Reactive IgG upon Human Rhinovirus Infection. |
Cell Rep |
2020 |
Eccles JD;Turner RB;Kirk NA;Muehling LM;Borish L;Steinke JW;Payne SC;Wright PW;Thacker D;Lahtinen SJ;Lehtinen MJ;Heymann PW;Woodfolk JA |
View
More |
| 32546721
|
A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro. |
Sci Rep |
2020 |
Behzadi MA;Choi A;Duehr J;Feyznezhad R;Upadhyay C;Schotsaert M;Palese P;Nachbagauer R |
View
More |
| 32665420
|
Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies. |
J Clin Microbiol |
2020 |
Charlton CL;Kanji JN;Johal K;Bailey A;Plitt SS;MacDonald C;Kunst A;Buss E;Burnes LE;Fonseca K;Berenger BM;Schnabl K;Hu J;Stokes W;Zelyas N;Tipples G |
View
More |
| 32700671
|
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2. |
Euro Surveill |
2020 |
Zheng Z;Monteil VM;Maurer-Stroh S;Yew CW;Leong C;Mohd-Ismail NK;Cheyyatraivendran Arularasu S;Chow VTK;Lin RTP;Mirazimi A;Hong W;Tan YJ |
View
More |
| 32717056
|
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays. |
J Appl Lab Med |
2020 |
Merrill AE;Jackson JB;Ehlers A;Voss D;Krasowski MD |
View
More |
| 32753554
|
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. |
Science |
2020 |
Mateus J;Grifoni A;Tarke A;Sidney J;Ramirez SI;Dan JM;Burger ZC;Rawlings SA;Smith DM;Phillips E;Mallal S;Lammers M;Rubiro P;Quiambao L;Sutherland A;Yu ED;da Silva Antunes R;Greenbaum J;Frazier A;Markmann AJ;Premkumar L;de Silva A;Peters B;Crotty S;Sette A;Weiskopf D |
View
More |
| 32966269
|
Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. |
J Clin Invest |
2020 |
Woldemeskel BA;Kwaa AK;Garliss CC;Laeyendecker O;Ray SC;Blankson JN |
View
More |
| 33024281
|
Cross-reactive memory T cells and herd immunity to SARS-CoV-2. |
Nat Rev Immunol |
2020 |
Lipsitch M;Grad YH;Sette A;Crotty S |
View
More |
| 33178193
|
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis? |
Front Immunol |
2020 |
Beretta A;Cranage M;Zipeto D |
View
More |
| 33178220
|
Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines. |
Front Immunol |
2020 |
Reche PA |
View
More |
| 33208477
|
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing. |
J Clin Microbiol |
2021 |
Conklin SE;Martin K;Manabe YC;Schmidt HA;Miller J;Keruly M;Klock E;Kirby CS;Baker OR;Fernandez RE;Eby YJ;Hardick J;Shaw-Saliba K;Rothman RE;Caturegli PP;Redd AD;Tobian AAR;Bloch EM;Larman HB;Quinn TC;Clarke W;Laeyendecker O |
View
More |
| 33239605
|
Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the \'Common Cold\'. |
Med Sci Monit |
2020 |
Stefano GB;Kream RM |
View
More |
| 33296686
|
Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. |
Immunity |
2020 |
Bacher P;Rosati E;Esser D;Martini GR;Saggau C;Schiminsky E;Dargvainiene J;Schroder I;Wieters I;Khodamoradi Y;Eberhardt F;Vehreschild MJGT;Neb H;Sonntagbauer M;Conrad C;Tran F;Rosenstiel P;Markewitz R;Wandinger KP;Augustin M;Rybniker J;Kochanek M;Leypoldt F;Cornely OA;Koehler P;Franke A;Scheffold A |
View
More |
| 33582244
|
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. |
Transl Res |
2021 |
Dobano C;Santano R;Jimenez A;Vidal M;Chi J;Rodrigo Melero N;Popovic M;Lopez-Aladid R;Fernandez-Barat L;Tortajada M;Carmona-Torre F;Reina G;Torres A;Mayor A;Carolis C;Garcia-Basteiro AL;Aguilar R;Moncunill G;Izquierdo L |
View
More |
| 33767706
|
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. |
Front Immunol |
2021 |
Shah P;Canziani GA;Carter EP;Chaiken I |
View
More |
| 33780548
|
Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses. |
J Infect Dis |
2021 |
Ringlander J;Martner A;Nilsson S;Westin J;Lindh M;Hellstrand K |
View
More |
| 33822770
|
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63. |
J Clin Invest |
2021 |
Woldemeskel BA;Garliss CC;Blankson JN |
View
More |
| 33894205
|
Monoclonal antibody against VP0 recognizes a broad range of human parechoviruses. |
J Virol Methods |
2021 |
Tripathi L;Hietanen E;Merilahti P;Teixido L;Sanchez-Alberola N;Tauriainen S;Susi P |
View
More |
| 34012431
|
CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. |
Front Immunol |
2021 |
Taborska P;Strizova Z;Stakheev D;Sojka L;Bartunkova J;Smrz D |
View
More |
| 34127926
|
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity. |
Front Immunol |
2021 |
Lehmann AA;Kirchenbaum GA;Zhang T;Reche PA;Lehmann PV |
View
More |
| 34509646
|
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. |
Infect Genet Evol |
2021 |
Tan CCS;Owen CJ;Tham CYL;Bertoletti A;van Dorp L;Balloux F |
View
More |
| 34676585
|
Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19. |
J Med Virol |
2022 |
Montalvo Villalba MC;Sosa Glaria E;Rodriguez Lay LLA;Valdes Ramirez O;Vallina Garcia D;Arencibia Garcia A;Martinez Alfonso J;Menes Llerena DM;Torres Perez L;Resik Aguirre SR;Guzman Tirado MG |
View
More |
| 34800846
|
Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing. |
Diagn Microbiol Infect Dis |
2022 |
Boschiero MN;Duarte A;Palamim CVC;Alvarez AE;Mauch RM;Marson FAL |
View
More |
| 34853366
|
Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 Antigen assay kit for the diagnosis of COVID-19. |
Sci Rep |
2021 |
Saito K;Ai T;Kawai A;Matsui J;Fukushima Y;Kikukawa N;Kyoutou T;Chonan M;Kawakami T;Hosaka Y;Misawa S;Takagi H;Matsushita Y;Hiki M;Okuzawa A;Hori S;Naito T;Miida T;Takahashi K;Tabe Y |
View
More |
| 34919800
|
HLA-A( *)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. |
Cell Rep |
2021 |
Nesterenko PA;McLaughlin J;Tsai BL;Burton Sojo G;Cheng D;Zhao D;Mao Z;Bangayan NJ;Obusan MB;Su Y;Ng RH;Chour W;Xie J;Li YR;Lee D;Noguchi M;Carmona C;Phillips JW;Kim JT;Yang L;Heath JR;Boutros PC;Witte ON |
View
More |
| 35328398
|
Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. |
Int J Mol Sci |
2022 |
Tajuelo A;Lopez-Siles M;Mas V;Perez-Romero P;Aguado JM;Briz V;McConnell MJ;Martin-Galiano AJ;Lopez D |
View
More |
| 36917669
|
Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age. |
Proc Natl Acad Sci U S A |
2023 |
Humbert M;Olofsson A;Wullimann D;Niessl J;Hodcroft EB;Cai C;Gao Y;Sohlberg E;Dyrdak R;Mikaeloff F;Neogi U;Albert J;Malmberg KJ;Lund-Johansen F;Aleman S;Bjorkhem-Bergman L;Jenmalm MC;Ljunggren HG;Buggert M;Karlsson AC |
View
More |
| 37186902
|
Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants. |
Libyan J Med |
2023 |
Shamabadi NS;Bagasra AB;Pawar S;Bagasra O |
View
More |
| 37638498
|
Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization. |
J Med Virol |
2023 |
Bochkov YA;Devries M;Tetreault K;Gangnon R;Lee S;Bacharier LB;Busse WW;Camargo CA;Choi T;Cohen R;De R;DeMuri GP;Fitzpatrick AM;Gergen PJ;Grindle K;Gruchalla R;Hartert T;Hasegawa K;Khurana Hershey GK;Holt P;Homil K;Jartti T;Kattan M;Kercsmar C;Kim H;Laing IA;Le Souef PN;Liu AH;Mauger DT;Pappas T;Patel SJ;Phipatanakul W;Pongracic J;Seroogy C;Sly PD;Tisler C;Wald ER;Wood R;Lemanske RF Jr;Jackson DJ;Gern JE |
View
More |
| 4126194
|
Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences. |
J Virol |
1973 |
Yin FH;Lonberg-Holm K;Chan SP |
View
More |
| 4317512
|
Reciprocal neutralizing cross-reaction between rhinovirus types 9 and 32. |
J Immunol |
1970 |
Cooney MK;Kenny GE |
View
More |
| 4337547
|
Studies with a rhinovirus of bovine origin. V. Serological relationships between the RS3x and other bovine rhinovirus strains. |
Arch Gesamte Virusforsch |
1972 |
Ide PR;Darbyshire JH |
View
More |
| 4344317
|
Recovery and characterization of non-cytopathogenic rhinoviruses. |
J Gen Virol |
1972 |
Olson LC;Willhight M;Buescher EL |
View
More |
| 4351585
|
Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera. |
Infect Immun |
1973 |
Cooney MK;Kenny GE;Tam R;Fox JP |
View
More |
| 4359785
|
Acid lability of rhinoviruses: loss of C and D antigenicity after treatment at pH 3.0. |
J Immunol |
1974 |
Hughes JH;Chema S;Lin N;Conant RM;Hamparian VV |
View
More |
| 4371278
|
Coronavirus infection in acute lower respiratory tract disease of infants. |
J Infect Dis |
1974 |
McIntosh K;Chao RK;Krause HE;Wasil R;Mocega HE;Mufson MA |
View
More |
| 4373761
|
Rhinoviruses: an antigenic study of the prototype virus strains. |
Proc Soc Exp Biol Med |
1974 |
Schieble JH;Fox VL;Lester F;Lennette EH |
View
More |
| 47360
|
Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes. |
J Immunol |
1975 |
Cooney MK;Wise JA;Kenny GE;Fox JP |
View
More |
| 6196431
|
Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants. |
J Exp Med |
1983 |
Gaston JS;Rickinson AB;Epstein MA |
View
More |
| 6202783
|
Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants. |
J Immunol |
1984 |
Stukart MJ;Boes J;Melief CJ |
View
More |
| 6206168
|
The common cold: control? |
J Infect Dis |
1984 |
Couch RB |
View
More |
| 6273696
|
Sequential passages of human rotavirus in MA-104 cells. |
Microbiol Immunol |
1981 |
Urasawa T;Urasawa S;Taniguchi K |
View
More |
| 6288568
|
Antigenic groupings of 90 rhinovirus serotypes. |
Infect Immun |
1982 |
Cooney MK;Fox JP;Kenny GE |
View
More |
| 6604611
|
Anti-influenza human T killer cells present an intertypic activity anti-A and -B type viruses in a secondary reaction in vitro. |
Clin Exp Immunol |
1983 |
Sitbon M;Gomard E;Hannoun C;Levy JP |
View
More |
| 7530390
|
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. |
Virology |
1995 |
Padilla-Noriega L;Dunn SJ;Lopez S;Greenberg HB;Arias CF |
View
More |
| 7595358
|
Molecular relationships between 21 human rhinovirus serotypes. |
J Gen Virol |
1995 |
Horsnell C;Gama RE;Hughes PJ;Stanway G |
View
More |
| 7679749
|
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. |
J Virol |
1993 |
Graham S;Wang EC;Jenkins O;Borysiewicz LK |
View
More |
| 7681440
|
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. |
J Clin Microbiol |
1993 |
Padilla-Noriega L;Werner-Eckert R;Mackow ER;Gorziglia M;Larralde G;Taniguchi K;Greenberg HB |
View
More |
| 8194515
|
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. |
EMBO J |
1994 |
Tormo J;Blaas D;Parry NR;Rowlands D;Stuart D;Fita I |
View
More |
| 8380098
|
Human rotavirus K8 strain represents a new VP4 serotype. |
J Virol |
1993 |
Li B;Larralde G;Gorziglia M |
View
More |
| 8395075
|
Reactivity of anti-human rotavirus VP4 neutralizing monoclonal antibodies with animal rotaviruses and with unusual human rotaviruses having different P and G serotypes. |
Res Virol |
1993 |
Kobayashi N;Taniguchi K;Urasawa T;Urasawa S |
View
More |
| 8972569
|
Epitope mapping of monoclonal antibodies raised to recombinant Mengo 3D polymerase. |
Virus Genes |
1996 |
Duque H;Palmenberg AC |
View
More |
| 9880807
|
Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries. |
J Biochem |
1999 |
Itoh K;Nakagomi O;Suzuki K;Inoue K;Tada H;Suzuki T |
View
More |
